drugset
drugset / Trial / NCT02571283

Peri-articular Injection Utilizing a Pain Cocktail With and Without Exparel

NCT02571283 ↗

Phase 4 Withdrawn University of Louisville Arthroplasty Foundation, Inc. · collab
RandomizedParallel-groupSingle-blindSupportive care

Summary

A prospective, randomized control study will be conducted to compare postoperative pain control in a series of patients treated with either: 1. a local cocktail. 2. a local cocktail plus Exparel. 3. marcaine plus Exparel prior to wound closure following knee arthroplasty.

Timeline

Start
2015-10
Primary completion
2016-05
Completion
2016-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupivacaine Other / unclassified 0.5 % Other
Subject Bupivacaine Other / unclassified 3 ml Other
Subject Bupivacaine Other / unclassified 13.3 mg/ml Other
Subject Bupivacaine Other / unclassified 20 ml Other
Subject Clonidine Other / unclassified 0.1 mg/ml Other
Subject Epinephrine Other / unclassified 1 mg/ml Other
Subject Ketorolac Other / unclassified 30 mg/ml Other
Subject Ropivacaine Other / unclassified 5 mg/ml Other

Indications

No indication recorded.